Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 16 de 16
Filter
1.
J Endocrinol Invest ; 45(11): 2165-2170, 2022 Nov.
Article in English | MEDLINE | ID: mdl-35854182

ABSTRACT

CONTEXT: Hypogonadism in Prader-Willi syndrome (PWS) is generally attributed to hypothalamic dysfunction or to primary gonadal defect. MKRN3, a maternal imprinted gene located on 15q11.2-q13 region, encodes makorin ring finger protein 3, whose deficiency causes precocious puberty, an extremely rare symptom in PWS. OBJECTIVE: This study aimed to evaluate MKRN3 levels in patients with PWS and to analyze its correlation with sexual hormone levels, insulin resistance and Body Mass Index (BMI). METHODS: We performed an observational cross-sectional study and enrolled 80 patients with genetically confirmed diagnosis of PWS with median age of 9.6 years. RESULTS: MKRN3 levels were measurable in 49 PWS patients with a geometric mean of 34.9 ± 22 pg/ml (median: 28.4). Unmeasurable levels of MKRN3 were found in 31 patients. No statistically significant differences were found between patients with and without measurable MKRN3 levels for any clinical, biochemical, or genetic characteristics. However, MKRN3 levels were inversely correlated with HOMA-IR index (p: 0.005) and HbA1c (p: 0.046) values. No statistically significant correlations were found between MKRN3 and LH, estradiol and testosterone concentrations, pubertal development and genetic defect, whereas a direct correlation with FSH was found (p: 0.007). CONCLUSIONS: The typical genetic defect of PWS should lead to unmeasurable levels of the MKRN3 protein due to the inactivation of the paternal allele. Measurable circulating MKRN3 could suggest the possible involvement of tissue-specific imprinting mechanisms and other regulatory factors in gene expression. Correlations with HOMA-IR index, HbA1c, and FSH suggest peripheral actions of MKRN3, but future studies are warranted to investigate this topic.


Subject(s)
Prader-Willi Syndrome , Child , Cross-Sectional Studies , Estradiol , Follicle Stimulating Hormone , Glycated Hemoglobin , Humans , Pilot Projects , Prader-Willi Syndrome/genetics , Testosterone , Ubiquitin-Protein Ligases/genetics
2.
Clin Microbiol Infect ; 22(4): 372-378, 2016 Apr.
Article in English | MEDLINE | ID: mdl-26806136

ABSTRACT

This study analysed the impact of PNPLA3 variants on liver histology of 168 HIV/hepatitis C virus (HCV)-coinfected patients who were naïve for HCV treatment. A athologist unaware of the patients' condition graded liver fibrosis and necroinflammation (Ishak) and steatosis (Kleiner). Patients were tested for PNPLA3 variants and genotyped for the PNPLA3 rs738409 C to G variant underlying the I148M substitution. All were hepatitis B surface antigen negative and stated no alcohol abuse. The mean age was 40.6 (37.6-44.1) years, 72.6% were males, 42% had HCV genotype 3, 38.9% HCV genotype 1 and 79.2% were receiving highly active antiretroviral therapy. The 79 patients with the PNPLA3 p.148I/M or M/M variants more frequently showed severe steatosis (score 3-4) than the 89 with PNPLA3 p.148I/I (43% vs. 24.7%, p 0.001), whereas no difference was observed in the degree of necroinflammation or fibrosis. Compared with 112 patients with lower scores, 56 with severe steatosis showed higher body mass index (p 0.03), higher rate of HCV genotype 3 (55.6% vs. 35.2%, p 0.01), PNPLA3 p.148I/M or M/M (60.7% vs. 39.3%, p 0.01) and lower CD4(+) cells/mm(3) (514.00 (390.5-673.0) vs. 500.00 (399.0-627.0); p 0.002). At multivariate analysis, body mass index (p 0.01), HCV genotype 3 (p 0.006), CD4(+) cell count (p 0.005) and PNPLA3 p.148I/M or M/M variants (p 0.01) were found to be independent predictors of severe liver steatosis. The PNPLA3 p.148 I/M or M/M variants and CD4(+) cell count were the only independent predictors of severe steatosis in patients with HCV non-3 genotypes. This is the first study to show that among HIV/HCV-coinfected patients the PNPLA3 p.148I/M or M/M variant have substantially less impact on steatosis for those with HCV genotype 3 than non-genotype 3.


Subject(s)
Genetic Predisposition to Disease , HIV Infections/complications , Hepatitis C, Chronic/complications , Hepatitis C, Chronic/pathology , Lipase/genetics , Liver/pathology , Membrane Proteins/genetics , Polymorphism, Single Nucleotide , Adult , Amino Acid Substitution , Fatty Liver/pathology , Female , Genotype , Hepatitis C, Chronic/genetics , Histocytochemistry , Humans , Liver Cirrhosis/pathology , Male , Necrosis/pathology
3.
Dig Liver Dis ; 39(3): 228-31, 2007 Mar.
Article in English | MEDLINE | ID: mdl-17267307

ABSTRACT

BACKGROUND: Coeliac disease is a complex disorder influenced by environmental and genetic factors. A genome wide linkage study identified the myosin IXB (MYO9B) as a gene possibly associated with coeliac disease. Recently, a Dutch study reported a strong association of a single SNP, rs 2305764, of MYO9B with coeliac disease. However, two successive studies carried out on British and Swedish/Norwegian cohorts reported lack of association of the MYO9B variant with coeliac disease. AIMS: The aim of the present study is to verify the effects of the MYO9B rs 2305764 polymorphism on disease risk in a Mediterranean population of coeliac children. PATIENTS AND METHODS: To address this issue, an association study was performed in 223 (127 females) Italian coeliac children and adolescents and in 600 controls. RESULTS: The allelic frequencies of the MYO9B rs 2305764 polymorphism found in our patients and in the population control were not statistically different (P=0.46). CONCLUSION: The MYO9B gene rs 2305764 polymorphism is not associated to coeliac disease in coeliac children from Southern Italy. This is in accordance with the most recent reports. Ethnic differences or a false positive result might explain the discrepancy with the Dutch study.


Subject(s)
Celiac Disease/genetics , Genetic Predisposition to Disease/genetics , Myosins/genetics , Polymorphism, Single Nucleotide , Adolescent , Case-Control Studies , Child , Child, Preschool , Cohort Studies , Female , Gene Frequency , Genetic Predisposition to Disease/epidemiology , Humans , Infant , Italy/epidemiology , Male , Polymorphism, Genetic , White People/genetics
5.
Diabetes ; 50(9): 2157-60, 2001 Sep.
Article in English | MEDLINE | ID: mdl-11522684

ABSTRACT

Cocaine- and amphetamine-regulated transcript (CART) inhibits feeding and induces the expression of c-Fos in hypothalamic areas implicated in appetite regulation. Furthermore, the CART peptide is found in neurons regulating sympathetic outflow, which in turn play an integral role in regulating body temperature and energy expenditure. The CART gene was screened by single-strand conformation polymorphism and automatic sequencing in 130 (72 girls) unrelated obese Italian children and adolescents. Their Z-scores (mean +/- SD) of relative to BMI percentiles was 3.9 +/- 1.8, and the average age at obesity onset was 4.7 +/- 2.6 years. Two previously described silent polymorphisms were found in the 3' untranslated region: an adenine deletion at position 1457 in 9 patients (allele frequency 0.035) and an A/G substitution at position 1475 in 11 patients (allele frequency 0.042). We found no difference between the obese patients heterozygous for one of these polymorphisms and those patients homozygous for the wild allele with respect to their age of obesity onset, BMI Z-scores, and leptin levels. A missense mutation of G729C resulting in the substitution of Leu with Phe at codon 34, within the NH2-terminal CART region, has been detected in the heterozygous state in a 10-year-old obese boy who has been obese since the age of 2 years. The patient belongs to a large family of obese subjects. The mutation cosegregated with the severe obesity phenotype over three generations and was not found in the control population. Resting metabolic rates were lower than expected in the propositus (-14%) and his mother (-16%), who carried the mutation. Leucine at codon 34, conserved in this position in the human and in the rat sequences, immediately precedes a couple of lysine residues that may well represent a dibasic processing site. The Leu34Phe mutation might alter the susceptibility to proteolysis of this potential processing site, likely altering the CART effect on thermogenesis and energy expenditure.


Subject(s)
Genetic Testing , Mutation , Nerve Tissue Proteins/genetics , Obesity/genetics , Adolescent , Amino Acid Sequence/genetics , Base Sequence/genetics , Child , Child, Preschool , Energy Metabolism/genetics , Female , Humans , Male , Molecular Sequence Data , Mutation/physiology , Mutation, Missense/genetics , Pedigree , Phenotype , Polymorphism, Single-Stranded Conformational , Rest
6.
Leukemia ; 15(3): 440-4, 2001 Mar.
Article in English | MEDLINE | ID: mdl-11237068

ABSTRACT

The erythrocyte skeleton plays an essential role in determining the shape and deformability of the red cell. Disruption of the interaction between components of the red cell membrane skeleton may cause loss of structural and functional integrity of the membrane. Several observations based on studies in vitro strongly suggest that phosphorylation may modify interactions between proteins, leading to a reduced affinity. In particular, increased phosphorylation of beta-spectrin decreases membrane mechanical stability. In order to investigate the presence of membrane protein defects we investigated the erythrocyte membrane protein composition and phosphorylation in 22 children with leukemia at diagnosis and during the remission phase. Sixteen children had acute lymphoblastic leukemia (ALL), three had chronic myeloid leukemia (CML) and three had acute myeloid leukemia (AML). Ten patients (eight ALL and two CML) displayed elliptocytosis and poikilocytosis, an increase of spectrin dimers (41.8 +/- 15.6) and an enhanced phosphorylation of beta-spectrin (108 +/- 15%) at diagnosis. These alterations disappeared during the remission phase. This is the first demonstration of a reversible erythrocyte membrane alteration in leukemia. Since the beta-spectrin phosphate sites are located near the C-terminal region and close to the head of the beta-chain that is involved in dimer-dimer interaction, we supposed that the beta-chain phosphorylation has an effect upon the interactions between spectrin dimers, ie the tetramerization process. The weakening of this process should be responsible for the presence of elliptocytes and poikilocytes as reported in hereditary elliptocytosis and pyropoikilocytosis.


Subject(s)
Erythrocytes/ultrastructure , Leukemia, Myelogenous, Chronic, BCR-ABL Positive/blood , Leukemia, Myeloid/blood , Precursor Cell Lymphoblastic Leukemia-Lymphoma/blood , Spectrin/metabolism , Acute Disease , Adolescent , Autoradiography , Child , Female , Humans , Male , Phosphorylation , Remission Induction
7.
Eur J Hum Genet ; 9(11): 873-6, 2001 Nov.
Article in English | MEDLINE | ID: mdl-11781706

ABSTRACT

We investigated the molecular basis of hyperekplexia (STHE), an inherited neurological disorder characterised by neonatal hypertonia and an exaggerated startle response, in a kindred and identified a novel missense mutation in the pore-lining M2 domain of the alpha1 subunit of the glycine receptor (GLRA1). Sequencing analysis of all exons of the GLRA1 gene revealed a G1158A base transition in affected, heterozygous patients. The base transition results in a valine to methionine substitution at codon 260 in the middle of the M2 transmembrane domain. The location within the M2 domain suggests for this substitution a likely role in altering ion channel properties.


Subject(s)
Nervous System Diseases/genetics , Receptors, Glycine/genetics , Amino Acid Sequence , Base Sequence , Binding Sites/genetics , DNA/chemistry , DNA/genetics , DNA Mutational Analysis , Family Health , Female , Humans , Male , Membrane Proteins/genetics , Molecular Sequence Data , Mutation, Missense , Pedigree , Reflex, Startle/genetics , Sequence Homology, Amino Acid
8.
J Pediatr ; 136(4): 556-9, 2000 Apr.
Article in English | MEDLINE | ID: mdl-10753261

ABSTRACT

The molecular basis for the considerable variation of serum bilirubin levels and the incidence of gallstone formation in patients with congenital dyserythropoietic anemia (CDA) type II are unknown. We show that the combined effect of an increased bilirubin load caused by dyserythropoiesis in CDA II and decreased bilirubin conjugation caused by reduced expression of uridine diphosphate glucuronosyl transferase (UGT1A) would increase the risk of hyperbilirubinemia (P <.005) and gallstone formation (chi(2): P <. 001). The rate of gallstone formation in patients with CDA II is 4. 75-fold the rate of patients without Gilbert's syndrome, and gallstone diagnosis occurs at a younger age (P < 0.01). These findings should be considered during the follow-up of patients with CDA II.


Subject(s)
Anemia, Dyserythropoietic, Congenital/genetics , Genetic Variation , Gilbert Disease/genetics , Adolescent , Adult , Anemia, Dyserythropoietic, Congenital/complications , Child , Child, Preschool , Cholelithiasis/etiology , Cholelithiasis/genetics , Female , Gilbert Disease/complications , Homozygote , Humans , Hyperbilirubinemia/etiology , Hyperbilirubinemia/genetics , Italy , Male , Monosaccharide Transport Proteins/genetics , Pedigree , Phenotype , Retrospective Studies
9.
Hematol J ; 1(3): 146-52, 2000.
Article in English | MEDLINE | ID: mdl-11920183

ABSTRACT

INTRODUCTION: In hereditary spherocytosis, erythropoiesis has been described as 'sluggish' during the first months of life. The lack of appropriate erythropoietic response to compensate for increased red cell destruction necessitates blood transfusions in 70-80% of hereditary spherocytosis-affected infants during their first year of life. After this period, less than 30% require regular transfusion support. This transient requirement for transfusion led us to wonder whether anemic hereditary spherocytosis infants, like anemic premature infants, could benefit from recombinant erythropoietin therapy (rHu-Epo). MATERIAL AND METHODS: In 16 hereditary spherocytosis infants (age range 16-119 days) with severe anemia, a compassionate open preliminary study was performed. rHu-Epo treatment (1000 IU/kg/week) was instituted together with iron supplementation. Hemoglobin values and reticulocyte counts were repeatedly assessed. RESULTS: In 13 out of 16 infants, prompt increases in reticulocyte counts were noted after the first week of treatment with 1000 IU/kg/week of rHu-Epo. During treatment with Epo these infants maintained clinically acceptable levels of hemoglobin and did not require blood transfusions. As the infants grew and began to mount an adequate erythropoietic response, the rHu-Epo dose could be tapered and the treatment could be discontinued before the age of nine months. CONCLUSION: Epo treatment in most hereditary spherocytosis infants appears to be effective in the management of anemia and could serve as a valuable alternative to packed RBC transfusions.


Subject(s)
Erythropoietin/therapeutic use , Hemoglobins/metabolism , Reticulocyte Count , Spherocytosis, Hereditary/therapy , Blood Transfusion , Erythrocyte Transfusion , Female , Genomic Imprinting , Gestational Age , Hemoglobins/drug effects , Humans , Infant , Infant, Newborn , Iron/therapeutic use , Male , Recombinant Proteins , Spherocytosis, Hereditary/blood , Spherocytosis, Hereditary/genetics
10.
Blood ; 94(7): 2259-62, 1999 Oct 01.
Article in English | MEDLINE | ID: mdl-10498597

ABSTRACT

The precocious formation of bilirubinate gallstones is the most common complication of hereditary spherocytosis (HS), and the prevention of this problem represents a major impetus for splenectomy in many patients with compensated hemolysis. Because Gilbert syndrome has been considered a risk factor for gallstone formation, there are reasons for postulating that the association of this common inherited disorder of hepatic bilirubin metabolism with HS could increase cholelithiasis. To test this hypothesis, 103 children with mild to moderate HS who, from age 1, have undergone a liver and biliary tree ultrasonography every year, were retrospectively examined. The 2-bp (TA) insertion within the promoter of the uridine diphosphate-glucuronosyltransferase gene (UGT1A1), associated with Gilbert syndrome, was screened. The risk of developing gallstones was statistically different among the 3 groups of patients: homozygotes for the normal UGT1A1 allele, heterozygotes, and homozygotes for the allele with the TA insertion. Fitting a Cox regression model, in fact, a statistically significant hazard ratio of 2.19 (95% confidence interval: 1.31 to 3.66) was estimated from one to the next of these genetic classes. The individual proneness to form gallstones from TA insertion in the TATA-box of the UGT1A1 promoter should be considered during the follow-up of patients with HS. Although patients with HS were the only ones studied, extrapolating these data to patients who have different forms of inherited (eg, thalassemia, intraerythrocytic enzymatic deficiency) or acquired (eg, autoimmune hemolytic anemia, hemolysis from mechanical heart valve replacement) chronic hemolysis can be warranted.


Subject(s)
Cholelithiasis/genetics , Gilbert Disease/complications , Gilbert Disease/genetics , Glucuronosyltransferase/genetics , Spherocytosis, Hereditary/genetics , Adolescent , Anion Exchange Protein 1, Erythrocyte/deficiency , Anion Exchange Protein 1, Erythrocyte/genetics , Ankyrins/deficiency , Ankyrins/genetics , Child , Child, Preschool , Cholelithiasis/complications , Cholelithiasis/epidemiology , Erythrocyte Membrane/metabolism , Genetic Carrier Screening , Homozygote , Humans , Liver/diagnostic imaging , Probability , Promoter Regions, Genetic , Retrospective Studies , Risk Assessment , Spectrin/deficiency , Spectrin/genetics , Spherocytosis, Hereditary/complications , Spherocytosis, Hereditary/epidemiology , TATA Box , Ultrasonography
11.
Eur J Haematol ; 62(5): 307-10, 1999 May.
Article in English | MEDLINE | ID: mdl-10359058

ABSTRACT

In this study we analyzed the effect of the (TA)7 polymorphism of the UGT1A gene associated with Gilbert's syndrome in G6PD-deficient subjects during an acute hemolytic crisis (fabic crisis). DNA from 44 subjects originating from the same geographic area in Sardinia was analyzed for the UGT1A promoter polymorphism. The increase of unconjugated bilirubin level during fabic crisis and its relationship with UGT1A polymorphism was evaluated. The UGT1A (TA)7 TATA box variant was found in 9/44 (21%) of the G6PD deficient subjects examined. The median value for unit of increase of bilirubin (mg/dl)/unit of decrease of hemoglobin (g/dl) was higher in variant homozygous than in heterozygous and normal subjects. These findings imply a contribution of the UGT1A polymorphism associated to Gilbert's syndrome to development of the hyperbilirubinemia in G6PD deficient subjects during acute hemolytic anemia.


Subject(s)
Anemia, Hemolytic/genetics , Bilirubin/blood , Gilbert Disease/genetics , Glucosephosphate Dehydrogenase Deficiency/genetics , Glucuronosyltransferase/genetics , Polymorphism, Genetic , Anemia, Hemolytic/blood , Child , Child, Preschool , Glucosephosphate Dehydrogenase Deficiency/blood , Humans , Isoenzymes/genetics , Italy , TATA Box
12.
Haematologica ; 84(2): 99-102, 1999 Feb.
Article in English | MEDLINE | ID: mdl-10091404

ABSTRACT

BACKGROUND AND OBJECTIVE: The pathogenesis of the hyperbilirubinemia present in approximately 30% of neonates affected by glucose-6-phosphate dehydrogenase deficiency is an unsolved problem. We evaluated the effect of Gilbert's syndrome, the most common defect of bilirubin conjugation, on the hyperbilirubinemia of these neonates. DESIGN AND METHODS: One hundred and two neonates affected by glucose-6-phosphate dehydrogenase deficiency were enrolled in this study: 56 had hyperbilirubinemia and 46 had normal bilirubin levels. The analysis of the A(TA)nTAA motif in the promoter region of the UGT1A gene was performed by means of PCR, followed by separation on 6% denaturing polycrylamide gel. RESULTS: The frequency of the three different genotypes of the A(TA)nTAA motif was similar in the study and control groups. Our results demonstrated no difference in the percentage of homozygotes for the UGT1A (TA)7 variant associated with Gilbert's syndrome. INTERPRETATION AND CONCLUSIONS: These findings indicate that Gilbert's syndrome does not account for the hyperbilirubinemia occurring in some neonates with glucose-6-phosphate dehydrogenase deficiency. Furthermore our results suggest that hemolysis is not the major event in the pathogenesis of hyperbilirubinemia in these patients.


Subject(s)
Gilbert Disease/physiopathology , Glucosephosphate Dehydrogenase Deficiency/physiopathology , Jaundice, Neonatal/physiopathology , Humans , Infant, Newborn , Male
13.
Exp Hematol ; 26(9): 869-73, 1998 Aug.
Article in English | MEDLINE | ID: mdl-9694508

ABSTRACT

Congenital dyserythropoietic anemia type II (CDA-II) is the most common form of inherited dyserythropoiesis. Erythroid precursor and red blood cells (RBCs) show characteristic morphological abnormalities. Biochemical studies have shown that this disease is associated with reduced glycosylation activity, which endows band 3 (anion transporter) with peculiar characteristics. The life span of RBCs may be shortened in patients with CDA-II, a phenomenon that has been ascribed to this membrane defect. We analyzed seven unrelated patients with CDA-II and five control subjects. In all of the CDA-II patients, erythrocytes presented a band 3 that was thinner than usual and also migrated slightly faster on SDS-PAGE. Analysis of anion transport function in CDA-II RBC samples demonstrated decreased anion exchange activity per band 3 molecule. Furthermore, we observed that the CDA-II RBCs contained larger amounts of aggregate band 3 than control erythrocytes. Aggregate band 3 has been reported to bind naturally occurring antibodies that mediate the phagocytic removal of RBCs. We provide evidence that both the phagocytic index (RBCs/macrophage) and the amount of membrane-bound immunoglobulin (IgG) are elevated in CDA-II erythrocytes. Our results suggest that the mild hemolysis observed in patients with CDA-II may be ascribed to clusterization of band 3, which leads to IgG binding and phagocytosis, and not to a secondary modification of the cytoskeletal structure of RBCs.


Subject(s)
Anemia, Dyserythropoietic, Congenital/blood , Anion Exchange Protein 1, Erythrocyte/metabolism , Anions/blood , Anion Exchange Protein 1, Erythrocyte/chemistry , Erythrocyte Aging , Glycosylation , Hemagglutinins/metabolism , Hemolysis , Humans , Immunoglobulin G/metabolism , Ion Transport , Macromolecular Substances , Phagocytosis , Protein Conformation , Protein Processing, Post-Translational , Sulfates/blood
14.
Br J Haematol ; 93(4): 828-34, 1996 Jun.
Article in English | MEDLINE | ID: mdl-8703812

ABSTRACT

We report a case of apparently recessive hereditary spherocytosis in an Italian child. The proband exhibited a reduction of overall ankyrin in the red cell membrane. The parents were free of any haematological manifestations. The VNDR associated with the ankyrin gene (ANK1) were consistent with the following diplotypes: AC11/ AC14 (father), AC14/AC14 (mother) and AC11/AC14 (child). The cDNA of the patient disclosed the expression of the AC11 allele only. As a consequence, we put forward the hypothesis of a de novo inactivation affecting the ankyrin allele of maternal origin (AC14) and accounting for the disease. PCR amplification of exons, SSCP analysis and nucleotide sequencing disclosed a polymorphism: GAC --> AAC; Asp --> Asn in codon 328 of exon 10, and a one-nucleotide deletion : CTG --> CG in codon 573 of the exon 16. This frameshift mutation placed in phase the TGA triplet that normally overlaps codons 636 and 637. Termination of translation near the middle of ankyrin mRNA coding sequence resulted, presumably, in its premature degadation. The present allele has been designated allele Napoli.


Subject(s)
Ankyrins/genetics , Frameshift Mutation , Spherocytosis, Hereditary/genetics , Amino Acid Sequence , Base Sequence , Child , Erythrocyte Membrane/metabolism , Exons , Female , Humans , Molecular Sequence Data , Mutation , Polymorphism, Genetic
16.
Hum Genet ; 89(5): 553-6, 1992 Jul.
Article in English | MEDLINE | ID: mdl-1353056

ABSTRACT

alpha I/65 Hereditary elliptocytosis (HE) is due to the duplication of TTG codon 154 (leucine) of alpha-spectrin and is associated with a constant haplotype. It was encountered exclusively in African and American Blacks, and in North Africans. We assumed that it diffused from the Benin-Togo area to Northern Africa. We now report two South Italian families with alpha I/65 HE. The phenotype fully conformed to previous descriptions. The mode of transmission was dominant; however, the manifestations were more pronounced when the common, low expression level alpha V/41 allele occurred in trans to the alpha I/65 allele, also conforming to previous records. The mutation underlying alpha I/65 HE turned out to be, again, the duplication of TTG codon 154 and the associated haplotype was the same as that encountered previously (+-+; XbaI, PvuII, MspI). Thus, the alpha I/65 allele found in Italy must have been introduced from North Africa across the Sicilian channel and would ultimately have originated from the Benin-Togo area. It would witness the same migratory stream as that followed by the Benin type haemoglobin S allele, which is also present in Southern Italy.


Subject(s)
Chromosome Aberrations , Elliptocytosis, Hereditary/genetics , Spectrin/genetics , Africa, Western , Base Sequence , Codon/genetics , Elliptocytosis, Hereditary/epidemiology , Female , Genes, Dominant , Humans , Immunoblotting , Infant , Infant, Newborn , Italy/epidemiology , Molecular Sequence Data , Pedigree , Polymorphism, Restriction Fragment Length , Repetitive Sequences, Nucleic Acid , Sicily/epidemiology
SELECTION OF CITATIONS
SEARCH DETAIL
...